US HB7180

Amends Section 1238 of the National Defense Authorization Act for Fiscal Year 2023 to update the interagency counter-narcotics strategy following the fall of the Assad regime in Syria

Expands geographic focus from Syria specifically to the broader Middle East region, with particular concern for shifting drug production and trafficking patterns into Iraq

Requires an unclassified, written strategy assessing Captagon, methamphetamine, and amphetamine-type stimulant production and trafficking within the U.S. Central Command area of responsibility

Mandates the strategy include identification of transit countries, assessment of counter-narcotics capacity, evaluation of U.S. training programs, and review of international cooperation efforts

Targets trafficking networks linked to the former Assad regime, Hezbollah, and Iran-backed proxies